<qa>  What is the primary endpoint of the study?It will be done a randomized triple-blind study comparing 0,2 polidocanol versus 75 hypertonic glucose of sclerotherapy in lower limbs telangiectasis. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency CEAP 1. The primary endpoint will be efficacy, and secondary will be safety. 